These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28671041)

  • 21. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
    Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
    Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPOCK1 Is a Novel Transforming Growth Factor-β-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer.
    Fan LC; Jeng YM; Lu YT; Lien HC
    PLoS One; 2016; 11(9):e0162933. PubMed ID: 27626636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: Comparative study with invasive ductal carcinoma-not otherwise specified.
    Li W; Yang D; Wang S; Guo X; Lang R; Fan Y; Gu F; Zhang X; Niu Y; Yan X; Fu L
    Pathol Res Pract; 2011 Dec; 207(12):739-46. PubMed ID: 22051146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of CacyBP is associated with poor prognosis and the effects on COX-2 expression in breast cancer.
    Nie F; Yu XL; Wang XG; Tang YF; Wang LL; Ma L
    Int J Oncol; 2010 Nov; 37(5):1261-9. PubMed ID: 20878073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between SLP-2 expression and prognosis in laryngeal squamous cell carcinoma and mammary invasive carcinoma].
    Cao WF; Zhang LY; Zhang B; Liu MB; Liu ZH; Sun BC
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):332-7. PubMed ID: 20654157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of nucleobindin 2 is associated with poor prognosis in gastric cancer.
    Altan B; Kaira K; Okada S; Saito T; Yamada E; Bao H; Bao P; Takahashi K; Yokobori T; Tetsunari O; Nishiyama M; Yamada M
    Tumour Biol; 2017 Jul; 39(7):1010428317703817. PubMed ID: 28714371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer.
    Xu X; Tang X; Lu M; Tang Q; Zhang H; Zhu H; Xu N; Zhang D; Xiong L; Mao Y; Zhu J
    Exp Mol Pathol; 2014 Dec; 97(3):579-84. PubMed ID: 25445503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma.
    Pula B; Jethon A; Piotrowska A; Gomulkiewicz A; Owczarek T; Calik J; Wojnar A; Witkiewicz W; Rys J; Ugorski M; Dziegiel P; Podhorska-Okolow M
    Histopathology; 2011 Dec; 59(6):1249-60. PubMed ID: 22175904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of Tiam1 and Rac1 correlates with poor prognosis in hepatocellular carcinoma.
    Yang W; Lv S; Liu X; Liu H; Yang W; Hu F
    Jpn J Clin Oncol; 2010 Nov; 40(11):1053-9. PubMed ID: 20522449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
    Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of vacuole membrane protein 1 and its prognostic value in invasive ductal carcinoma of the breast].
    Liu F; Niu Y; Liu N; Zhang W; Wang SL; Liu H; Zhang TX
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):86-9. PubMed ID: 23710913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance.
    Zhang X; Zhang Y; Yang Y; Niu M; Sun S; Ji H; Ma Y; Yao G; Jiang Y; Shan M; Zhang G; Pang D
    Cancer Epidemiol; 2012 Jun; 36(3):288-93. PubMed ID: 21889920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast.
    Tsutsui S; Inoue H; Yasuda K; Suzuki K; Higashi H; Era S; Mori M
    Oncology; 2005; 68(4-6):398-404. PubMed ID: 16020969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.
    Jin H; Ji M; Chen L; Liu Q; Che S; Xu M; Lin Z
    J Exp Clin Cancer Res; 2016 Mar; 35():42. PubMed ID: 26955804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of Ubiquilin1 expression in invasive breast cancer.
    Wang Y; Lu J; Zhao X; Feng Y; Lv S; Mu Y; Wang D; Fu H; Chen Y; Li Y
    Cancer Biomark; 2015; 15(5):635-43. PubMed ID: 26406952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancer.
    Ramos FS; Serino LT; Carvalho CM; Lima RS; Urban CA; Cavalli IJ; Ribeiro EM
    Genet Mol Res; 2015 Jun; 14(2):6960-7. PubMed ID: 26125904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.